| Journal | Issue | Title | Abstract | File |
| REMEDIUM | No 3 (2022) | Changes in body mass index among students from different countries before and during the COVID-19 pandemic | Abstract |
 (Rus) |
| Mingazov R.N., Gureev S.A., Tliashinov A.O., Mingazova E.N. | ||||
| REMEDIUM | No 2 (2025) | Changes in the positions of domestic manufacturers in the regional market because of offset contracts’ supplies of medicinal products | Abstract |
(Rus) |
| Trofimova E.O., Aleshechkina Y.A. | ||||
| REMEDIUM | No 1-2 (2019) | Changes in VED list: an opportunity that came true | Abstract |
(Rus) |
| Prozherina J., Shirokova I. | ||||
| REMEDIUM | No 7-8 (2020) | Changing breast cancer prognosis | Abstract |
(Rus) |
| Prozherina Y., Shirokova I. | ||||
| REMEDIUM | No 4 (2023) | Characteristics of the structure of arriving foreign citizens in the Republic of Tatarstan | Abstract |
(Rus) |
| Minullin I.K., Vafina G.G., Bildyuk E.V., Garifullina I.V., Bychkova S.A., Eremeeva Z.G. | ||||
| REMEDIUM | No 11 (2018) | Characterization of export prospect of domestic anti-influenza vaccines in Latin American countries and Carribeans | Abstract |
(Rus) |
| Trukhin V.P., Narkevich I.A., Nacharova E.P., Uiba S.V., Basakina I.I. | ||||
| REMEDIUM | No 3 (2019) | Chelovek legche perenosit golod, chem poteryu sna. Interv'yu s Ol'goy Vorob'evoy | Abstract |
(Rus) |
| Article E. | ||||
| REMEDIUM | No 1-3 (2020) | Chem opasna bessonnitsa i kak s ney borot'sya? | Abstract |
(Rus) |
| Article E. | ||||
| REMEDIUM | No 11 (2019) | Chronic vein diseases: a pressing issue of our time | Abstract |
(Rus) |
| Beregovykh R., Prozherina Y. | ||||
| REMEDIUM | No 1-2 (2019) | Classification issues of GMP-inspection deficiencies: regulatory practices | Abstract |
(Rus) |
| Orlov V.A., Shestakov V.N. | ||||
| REMEDIUM | No 9 (2018) | Classification of the Republic of Sakha (Yakutia) municipal districts by level of pharmaceutical aid provided using mathematical methods | Abstract |
(Rus) |
| Tarabukina S.M., Moshkova L.V. | ||||
| REMEDIUM | No 11 (2018) | Climacteric syndrome: issues in modern pharmacotherapy | Abstract |
(Rus) |
| Prozherina J., Ilyukhina E. | ||||
| REMEDIUM | No 2 (2024) | Clinical and economic evaluation of the use of favipiravir in treatment regimens for COVID-19 | Abstract |
(Rus) |
| Krysanov I.S., Gurevich K.G., Matveeva N.V., Matveev A.V., Zaslavskaya K.Y., Krysanova V.S., Ermakova V.Y., Kurkin D.V., Balykova L.A., Belyi P.A., Zemskov D.N., Makarova E.V. | ||||
| REMEDIUM | No 1-2 (2019) | clinical guidelines. history of creation and development in the Russian Federation and abroad | Abstract |
(Rus) |
| Kovaleva M.Y., Sukhorukikh O.A. | ||||
| REMEDIUM | No 11-12 (2020) | Clinical trials in the Coronavirus era: management of risks | Abstract |
(Rus) |
| Vodovozov A. | ||||
| REMEDIUM | No 4 (2024) | Clinical — economic indicators of the effectiveness of pharmacotherapy in two different therapy for psoriasis vulgaris | Abstract |
(Rus) |
| Khokhlov A.L., Samarina E.I., Lileeva E.G. | ||||
| REMEDIUM | No 1-2 (2018) | Collecting of organizations' tax debts from its executives: how and when? | Abstract |
(Rus) |
| Lavrentieva A. | ||||
| REMEDIUM | No 9 (2019) | Combination of private and public interests in the legal regulation of gene technologies | Abstract |
(Rus) |
| Mokhov А.А., Yavorskiy A.N. | ||||
| REMEDIUM | No 3 (2023) | Communication barriers as a factor in reducing the effectiveness of campaigns on children's vaccination | Abstract |
(Rus) |
| Adamov D.A. | ||||
| REMEDIUM | No 10 (2020) | Comorbid patient with non-alcoholic fatty liver disease | Abstract |
(Rus) |
| Shirokova E.N. | ||||
| REMEDIUM | No 10 (2020) | Comparative analysis of business models of top pharmaceutical manufacturing companies: financial analysis | Abstract |
(Rus) |
| Yasinskaya L.E. | ||||
| REMEDIUM | No 3 (2024) | Comparative analysis of standards in the field of quality management system at all stages of the life cycle of medical devices | Abstract |
(Rus) |
| Gertsik Y.G., Roschin D.O., Aksenova A.M. | ||||
| REMEDIUM | No 1 (2023) | Comparative analysis of temporary guidelines for the prevention, diagnosis and treatment of new coronavirus infection | Abstract |
(Rus) |
| Motygullina L.I., Tukhbatullina R.G. | ||||
| REMEDIUM | No 3 (2025) | Comparative analysis of the assortment of the drug «Insulin» in various pharmaceutical market | Abstract |
(Rus) |
| Gribkova E.I., Vinogradova P.D., Ebzeeva A.M., Merkulov A.V., Tihonov A.V. | ||||
| REMEDIUM | No 9 (2020) | Comparison and analysis of the fda approved orphane drugs register and the vital and essential drugs list of the Russian Federation | Abstract |
(Rus) |
| Yurochkin D.S., Leshkevich A.A., Golant Z.M., Narkevich I.A. | ||||
| 101 - 125 of 832 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |||